{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T04:27:22Z","timestamp":1792902442273,"version":"4.5.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Natural killer (NK) cells are a promising allogeneic, off-the-shelf, cellular immunotherapy product. These cells can be manipulated ex vivo, genetically edited to enhance tumor targeting and expanded to produce large cell banks for multiple patient infusions. Therapeutic efficacy of these products depends on the recovery of viable and functional cells post-thaw. Post-thaw loss of viability and cytolytic activity results in large, and often variable, discrepancies between the intended cell dose (based on counts at cryopreservation) and the actual dose administered. Compared to their highly activated state in fresh culture, post-thaw NK cells demonstrate critical changes in cytokine production, cytotoxic activity, <jats:italic>in vivo<\/jats:italic> proliferation and migration. When these NK cells are introduced into the highly immunosuppressive tumor microenvironment, the functional changes induced by cryopreservation further limits the clinical potential of these products. This report will review the impact of cryopreservation on <jats:italic>ex vivo<\/jats:italic> expanded NK cells and outlines strategies described in published studies to recover post-thaw function.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1304689","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T09:24:15Z","timestamp":1702632255000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["Optimizing the cryopreservation and post-thaw recovery of natural killer cells is critical for the success of off-the-shelf platforms"],"prefix":"10.3389","volume":"14","author":[{"given":"Jennifer N.","family":"Saultz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Folashade","family":"Otegbeye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,12,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/imr.12793","article-title":"Cellular therapy: Adoptive immunotherapy with expanded natural killer cells","volume":"290","author":"Lee","year":"2019","journal-title":"Immunol Rev"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-04-419283","article-title":"Cytokine activation induces human memory-like NK cells","volume":"120","author":"Romee","year":"2012","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030264","article-title":"Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells","volume":"7","author":"Denman","year":"2012","journal-title":"PloS One"},{"key":"B4","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13045-020-00998-9","article-title":"Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy","volume":"13","author":"Yilmaz","year":"2020","journal-title":"J Hematol Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-09-077438","article-title":"Human natural killer cells","volume":"112","author":"Caligiuri","year":"2008","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-07-2974","article-title":"Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer","volume":"105","author":"Miller","year":"2005","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/319675a0","article-title":"Selective rejection of H\u20132-deficient lymphoma variants suggests alternative immune defence strategy","volume":"319","author":"K\u00e4rre","year":"1986","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202049028","article-title":"Human NK cells, their receptors and function","volume":"51","author":"Quatrini","year":"2021","journal-title":"Eur J Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature07665","article-title":"Adaptive immune features of natural killer cells","volume":"457","author":"Sun","year":"2009","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-01-070656","article-title":"Increased natural killer cell expression of CD16, augmented binding and ADCC activity to rituximab among individuals expressing the Fc{gamma}RIIIa-158 V\/V and V\/F polymorphism","volume":"110","author":"Hatjiharissi","year":"2007","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2020.05.001","article-title":"Analysis of ex vivo expanded and activated clinical-grade human NK cells after cryopreservation","volume":"22","author":"Damodharan","year":"2020","journal-title":"Cytotherapy"},{"key":"B13","doi-asserted-by":"publisher","first-page":"14916","DOI":"10.1038\/s41598-019-51287-6","article-title":"Membrane bound IL-21 based NK cell feeder cells drive robust expansion and metabolic activation of NK cells","volume":"9","author":"Ojo","year":"2019","journal-title":"Sci Rep"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4110\/in.2018.18.e31","article-title":"Optimization of large-scale expansion and cryopreservation of human natural killer cells for anti-tumor therapy","volume":"18","author":"Min","year":"2018","journal-title":"Immune Netw"},{"key":"B15","doi-asserted-by":"publisher","first-page":"357ra123","DOI":"10.1126\/scitranslmed.aaf2341","article-title":"Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia","volume":"8","author":"Romee","year":"2016","journal-title":"Sci Trans Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2022.02.008","article-title":"A phase I study to determine the maximum tolerated dose of ex vivo expanded natural killer cells derived from unrelated, HLA-disparate adult donors","volume":"28","author":"Otegbeye","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910607","article-title":"Use of CAR-transduced natural killer cells in CD19-positive lymphoid tumors","volume":"382","author":"Liu","year":"2020","journal-title":"New Engl J Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0312","article-title":"Multidimensional analyses of donor memory-like NK cells reveal new associations with response after adoptive immunotherapy for leukemia","volume":"10","author":"Berrien-Elliott","year":"2020","journal-title":"Cancer Discov"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2020.03.020","article-title":"Harnessing natural killer cells for the treatment of ovarian cancer","volume":"157","author":"Hoogstad-van Evert","year":"2020","journal-title":"Gynecol Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.pharmthera.2018.04.003","article-title":"Natural killer cells and their therapeutic role in pancreatic cancer: A systematic review","volume":"189","author":"Van Audenaerde","year":"2018","journal-title":"Pharmacol Ther"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1083462","article-title":"Focusing on NK cells and ADCC: A promising immunotherapy approach in targeted therapy for HER2-positive breast cancer","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03095","article-title":"Therapeutic potential of natural killer cells in gastric cancer","volume":"9","author":"Du","year":"2018","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00873","article-title":"Enhancing neuroblastoma immunotherapies by engaging iNKT and NK cells","volume":"11","author":"McNerney","year":"2020","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2450\/2015.0231-14","article-title":"A good manufacturing practice method to ex vivo expand natural killer cells for clinical use","volume":"13","author":"Torelli","year":"2015","journal-title":"Blood Transfus"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3109\/14653249.2012.700767","article-title":"Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications","volume":"14","author":"Lapteva","year":"2012","journal-title":"Cytotherapy"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2016.02.008","article-title":"Cryopreservation has no effect on function of natural killer cells differentiated in vitro from umbilical cord blood CD34(+) cells","volume":"18","author":"Domogala","year":"2016","journal-title":"Cytotherapy"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.861681","article-title":"Cryopreserved PM21-particle-expanded natural killer cells maintain cytotoxicity and effector functions in vitro and in vivo","volume":"13","author":"Oyer","year":"2022","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0022-1759(93)90102-D","article-title":"Human natural killer cells: a convenient purification procedure and the influence of cryopreservation on cytotoxic activity","volume":"165","author":"Voshol","year":"1993","journal-title":"J Immunol Methods"},{"key":"B29","doi-asserted-by":"publisher","first-page":"5224","DOI":"10.1038\/s41467-020-19094-0","article-title":"Cryopreservation impairs 3-D migration and cytotoxicity of natural killer cells","volume":"11","author":"Mark","year":"2020","journal-title":"Nat Commun"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-016-2247-8","article-title":"Cryopreserved NK cells in the treatment of haematological Malignancies: preclinical study","volume":"142","author":"Holubova","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/antib11010012","article-title":"Cryopreservation of natural killer cells pre-complexed with innate cell engagers","volume":"11","author":"Reusch","year":"2022","journal-title":"Antibodies"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1304689\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T09:24:19Z","timestamp":1702632259000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1304689\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,15]]},"references-count":31,"alternative-id":["10.3389\/fimmu.2023.1304689"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1304689","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,15]]},"article-number":"1304689"}}